Drug name - Cleviprex

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103490 CHIESI Clevidipine emulsion formulations containing antimicrobial agents Oct, 2031

(9 years from now)

US10010537 CHIESI Clevidipine emulsion formulations containing antimicrobial agents Oct, 2031

(9 years from now)

US8658676 CHIESI Clevidipine emulsion formulations containing antimicrobial agents Oct, 2031

(9 years from now)

Drugs and Companies using CLEVIDIPINE ingredient

Treatment: NA

Dosage: EMULSION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
25MG/50ML (0.5MG/ML) EMULSION;INTRAVENOUS Prescription
50MG/100ML (0.5MG/ML) EMULSION;INTRAVENOUS Prescription
125MG/250ML (0.5MG/ML) EMULSION;INTRAVENOUS Discontinued

availability in other generic markets.

Click on the highlighted region to filter.